Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma.
作者信息
Yeh Jennifer E, Wan Marilyn T, Alloo Allireza, Ibrahim Nageatte, Ott Patrick A, Buchbinder Elizabeth I, Lin Jennifer Y
机构信息
Department of Dermatology, Stanford University School of Medicine, Redwood City, California.
Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra Northwell, New Hyde Park, New York.
出版信息
JAAD Case Rep. 2022 Jul 22;27:162-166. doi: 10.1016/j.jdcr.2022.07.019. eCollection 2022 Sep.
Abstract
摘要
相似文献
1
Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma.
JAAD Case Rep. 2022 Jul 22;27:162-166. doi: 10.1016/j.jdcr.2022.07.019. eCollection 2022 Sep.
2
Protocol for the TIDAL Melanoma Study: topical imiquimod or diphenylcyclopropenone for the management of cutaneous in-transit melanoma metastases-a phase II, single centre, randomised, pilot study.
BMJ Open. 2017 Oct 6;7(10):e016816. doi: 10.1136/bmjopen-2017-016816.
3
Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
J Dermatol. 2016 May;43(5):553-6. doi: 10.1111/1346-8138.13197. Epub 2015 Dec 12.
4
Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.
J Immunother. 2012 Nov-Dec;35(9):716-20. doi: 10.1097/CJI.0b013e31827457bd.
5
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Ann Dermatol Venereol. 2014 Feb;141(2):106-10. doi: 10.1016/j.annder.2013.10.058. Epub 2014 Jan 14.
6
Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma.
Br J Dermatol. 2008 Sep;159(3):606-14. doi: 10.1111/j.1365-2133.2008.08709.x. Epub 2008 Jul 4.
7
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases.
JAAD Case Rep. 2022 Sep 17;31:62-65. doi: 10.1016/j.jdcr.2022.09.006. eCollection 2023 Jan.
8
The role of topical imiquimod in melanoma cutaneous metastases: A critical review of the literature.
Dermatol Ther. 2020 Nov;33(6):e14165. doi: 10.1111/dth.14165. Epub 2020 Sep 7.
9
Successful Treatment of In-Transit Metastatic Melanoma in a Renal Transplant Patient With Combination T-VEC/Imiquimod Immunotherapy.
J Immunother. 2020 May;43(4):149-152. doi: 10.1097/CJI.0000000000000319.
10
Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod.
Melanoma Res. 2016 Aug;26(4):409-12. doi: 10.1097/CMR.0000000000000247.
引用本文的文献
1
Successful treatment of in-transit metastatic melanoma with combination intralesional T-VEC and topical imiquimod immunotherapy.
J Immunother Cancer. 2024 Nov 19;12(11):e009581. doi: 10.1136/jitc-2024-009581.
2
Developing Engineered Nano-Immunopotentiators for the Stimulation of Dendritic Cells and Inhibition and Prevention of Melanoma.
Pharm Res. 2024 Jun;41(6):1163-1181. doi: 10.1007/s11095-024-03722-1. Epub 2024 Jun 5.
本文引用的文献
1
Long-term outcomes of imiquimod-treated lentigo maligna.
Clin Exp Dermatol. 2019 Aug;44(6):631-636. doi: 10.1111/ced.13896. Epub 2019 Jan 20.
2
Guidelines of care for the management of primary cutaneous melanoma.
J Am Acad Dermatol. 2019 Jan;80(1):208-250. doi: 10.1016/j.jaad.2018.08.055. Epub 2018 Nov 1.
3
SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study.
Cancer Discov. 2018 Oct;8(10):1250-1257. doi: 10.1158/2159-8290.CD-18-0280. Epub 2018 Aug 28.
4
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell. 2017 Sep 7;170(6):1109-1119.e10. doi: 10.1016/j.cell.2017.08.027.
5
Intratumoral injection of a CpG oligonucleotide reverts resistance to PD-1 blockade by expanding multifunctional CD8+ T cells.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7240-E7249. doi: 10.1073/pnas.1608555113. Epub 2016 Oct 31.
6
Treatment of in-transit and metastatic melanoma in two patients treated with ipilimumab and topical imiquimod.
Melanoma Res. 2016 Aug;26(4):409-12. doi: 10.1097/CMR.0000000000000247.
7
Local cryosurgery and imiquimod: A successful combination for the treatment of locoregional cutaneous metastasis of melanoma: A case series.
J Dermatol. 2016 May;43(5):553-6. doi: 10.1111/1346-8138.13197. Epub 2015 Dec 12.
8
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Nature. 2014 Nov 27;515(7528):568-71. doi: 10.1038/nature13954.
9
Effective innate and adaptive antimelanoma immunity through localized TLR7/8 activation.
J Immunol. 2014 Nov 1;193(9):4722-31. doi: 10.4049/jimmunol.1401160. Epub 2014 Sep 24.
10
Locoregional therapies in melanoma.
Surg Clin North Am. 2014 Oct;94(5):1003-15, viii. doi: 10.1016/j.suc.2014.07.004. Epub 2014 Aug 7.
Zotero 插件